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Abstract  Article Info 
Introduction: Nasopharyngeal carcinoma (NPC) is a malignancy of squamous cells on nasopharyngeal 
epithelial layer with Rosenmuller fossa with a high incidence especially in Asian region. There is three 
different histologic subtypes, namely squamous cell carcinoma, nonkeratinizing carcinoma, and 
undifferentiated carcinoma. Principle of management NPC is radiotherapy because of this kind of 
carcinoma highly radiosensitive and is the mainstay of treatment for all stages. But in advance case, we 
need combinatio of radiotherapy and chemotherapy 
Case report: We report a patient which came to the ENT-Head and Neck Surgery Outpatient Clinic of 
General Hospital Haji Adam Malik Medan with complaint of tinnitus in the right ear and nasal congestion 
on the right side. The patient then performed a contrast-enhanced nasopharyngeal MSCT scan with the 
result: T2aN0M0. The histopathology results : Non Keratinizing Squamous Cell Carcinoma. The patient 
was given 70 gy of Concurent Chemoradiation (CRT) followed by adjuvant chemotherapy with Cisplatin 
and 5 Flourouracil (FU).  
Conclusion: There was no visible mass on the nasopharynx after using this combination Radiation and 
Chemotherapy. 
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1. CASE REPORT 
A 47 years old man came to the ENT-Head and Neck Surgery 
Outpatient clinic of General Hospital Haji Adam Malik Medan on February 
20th, 2020 with complaint of tinnitus in the right ear and nasal congestion 
on the right side. This complaint has been felt by the patient since the 
previous 4 months. Previous history of tinnitus in the ears and nasal 
congestion was denied. History of habitual smoking was found since adol. 
History of consuming salted fish was found. There was no lump in the neck. 
There was no history of epistaxis. The patient then performed a contrast-
enhanced nasopharyngeal MSCT scan on February 21, 2020 with the result: 
T2N0M0. The histopathology results on March 9, 2020: Non-Keratinizing 
Squamous Cell Carcinoma. The patient was given 70 gy of Chemoradiation 
(CRT) accompanied through adjuvant chemotherapy with Cisplatin + 5 Fu 
for 3 cycles. During CRT, the radiation beam was given in single fraction 
which is 2.0 gy in one fraction every Monday to Friday. Before the radiation 
started, the patient has concurrent Chemotherapy, then followed after 15th 
and 30th radiation. After 35 times of radiation and 3 concurent 
chemotherapy, then continued in adjuvant chemotheraphy. The patient was 
evaluated on December 16, 2020 and from the contrast enhanced 
nasopharyngeal MSCT Scan, the results were: There was no visible mass on 
the nasopharynx. After this report was made there is no evidence the mass 
was came back. 
2. DISCUSSION 
Nasopharyngeal carcinoma (NPC) is a head-neck malignancy with an 
excessive occurrence mainly in Asian region. Also in developing country 
like indonesia NPC has highly prevalence in head-neck cancer with most of 
the type is squamous cell type 3 exclusive histologic subtypes, specifically 
squamous cell carcinoma, non-keratinizing cell carcinoma, and 
undifferentiated carcinoma [1]. In anatomical view, this tumor is bobbing 
up from the epithelial cells that cowl the floor of the nasopharynx. Data in 
2013, the prevalence of carcinoma in Indonesia was estimated to 1.4% or 
around 347,792 people which from General Hospital H. Adam Malik 
Medan, majority prevalence of nasopharyngeal cancer patients are Men [2, 
3]. Cigarette smoking additionally has enormous hazard element for 
inflicting most cancers especially in nasopharynx due to the additives of 
cigarette contents have carcinogenic capacity along with nitrosamines and 
formaldehyde [1]. Mucosa of nasopharynx may be immediately uncovered 
through cigarette smoke this is inhaled and may set off most cancers 
withinside the touch area [4]. But habitual smoking cannot be stand alone 
as a risk factors for NPC. There are many factors can be influence as a risk 
factor. Beside of that, habitual smoking can affect the clinical stadium of 
NPC [1]. In other case, consumption of salted fish has clearly increased the 
incidence of NPC case. The carcinogenic content in salted fish, such as 
nitrosamine, is one of the most etiologic factors was mentioned [5, 6].  The 
history of consumption salted fish since school age and the use of firewood, 
will increase each other as risk factors the incident of NPC. In Hasan Sadikin 
Bandung General risk factors that increase the prevelance of NPC consists 
of a long term of smoking (50.7%), use of mosquito repelling coils (43.2%), 
history of salted fish consumption (39.7%), alcohol consumption (14.1%), 
and a family history of cancer (7%) [7]. Succesful management and 
prognostic of NPC is clearly depand on are the stadium, WHO 
histopatological type, and age at diagnosis [8]. In this case we found 
unilateral tinitus and unilateral nasal blockage. NPC case in early stage is 
difficult to assess, because most of them has come after the tumor was 
growth and they have complaint about neck lump in different aspect the 
issue of early NPC prognosis is resulting from unspecified early signs 
consisting of ear and nostril complaints. In malignancy case, ear complaints 
typically best in unilateral aspect. But if the affected person got here early, 
it is able to be obtain greatest outcomes of treatment [9]. According of a 
previous study in Cipto Mangunkusumo General Hospital, about 58.1 % 
NPC patient has showed a neck lump. In this case patient dont have neck 
lump. According that clinical finding, this early stage has better prognosis. 







Yussy et al was showing in Hasan Sadikin Bandung General Hospital 
patient who was came with advanced stage tumors (T3-T4) were 76 (56%) 
and early stage tumor (T1-T2) were 59 (44%).  In that T3-T4 Stadium, they 
found reccurent case of NPC (10). Nasopharyngeal carcinoma is a rare 
malignancy in children. NPC case in children constitutes 1-5% of all 
pediatric cancers and 20-50% of all primary nasopharyngeal malignant 
tumors in children [11]. In this case, age of patient is 47 years old. In high-
incidence area, ages of 40-60 years old was the most prevalence [12]. 
Diagnostic tools for this case is use CT Scan and Histopathology but 
histopathology result is still as a gold standart for diagnosis of NPC (13). 
Report from Lily et al, diagnostic device which may be used to decide the 
degree is the use of radiological content material consisting of Computed 
Tomography Scanning (CT-Scan) with contrast, Ultrasonography (USG) 
and thorax rontgen [13]. 
According to Setiani et al Retrospective studies finished through 
evaluating radiation doses, they observed that the radiation dose given >60 
Gy, 5-12 months sickness unfastened survival charge turned into reached to 
70% in T1-T2 sufferers in comparison to simplest 20% in T3-T4 [13]. 
According to NCCN 2021, staging in NPC was described here [14]:  
 
Table 1. Tumour in Nasopharynx (T) 
Tx Primary tumour cannot be assessed 
T0 No diagnosed tumour, however fine cervical EBV involvement 
T1 Tumour is restricted in nasopharynx or expands to oropharynx 
nasal hollow space with none enlargement to parapharyngeal 
area 
T2 Tumour with enlargement to parapharyngeal area or adjoining 
tender tissue involvement (medial pterygoid, lateral pterygoid, 
and prevertebral muscles) 
T3 Tumour erodes the bone and or paranasal sinuses 
T4 Tumour expands intracranially and or invades the cranial 
nerves, infratemporal fossa, hypopharynx or orbit, parotid 
gland, and or good-sized gentle tissue infiltration out of doors 
the floor of lateral pterygoid muscle. 
According to this case, the tumor was on right side of nasopharynx and 
expanded to the parapharynx. There is no destruction of skull base bone. So 
we conclude this tumor is in T2 staging. 
Table 2. Lymph Nodes (N) 
Nx Regional lymph nodes cannot be determined 
N0 No metastasis to local lymph nodes 
N1 Metastasis to unilateral local lymph nodes, with the 
dimensions of 6 cm or less, above the caudal margin of cricoid 
cartilage 
N2 Metastasis to bilateral local lymph nodes, with the dimensions 
of 6 cm or less, above the caudal margin of cricoid cartilage 
N3 Metastasis to the lymph nodes of the cervix unilaterally or 
bilaterally, with the biggest length of extra than 6 cm, and  or 
extension to the place beneathneath the margin of cricoid 
cartilage 
According to this case, from Iv-Contrast Nasopharyngeal Scan 
there is no metastasis to the regional lymph nodes, so in Lymph nodes 
staging was N0. 
Table 3. Distant Metastasis (M) 
In this case there is no distant metastasis. So we conclude in this case staging 
was T2N0M0 (Stadium II).  
 
Table 4. Staging 
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Stage 4B Any T Any N M1 
According on this case, this patient was giving combination of 
Radiotherapy (RT) and concurrent chemotherapy. After giving 
Chemoradiotherapy (CRT), then the patient is continued with adjuvant 
chemotherapy. Principle of management NPC is radiotherapy because of 
this kind of carcinoma highly radiosensitive and is primary treatment for all 
stages [5]. In other side, combination of definitive radiotherapy (RT) and 
addition with concurrent chemotherapy is the standard treatment for patients 
with loco-regionally advanced NPC [14]. Agent of chemotherapy regiment 
for NPC is Platinum-primarily based totally which include cisplatin, 
carboplatin, and oxaliplatin, satraplatin, and transplatin. Platinum primarily 
based totally agent were used notably in clinics seeing that thirty years in 
the past withinside the remedy of malignant head-neck tumors [15]. 
Table 5. Management of NPC (16) 
 
Stage NCCN (2018) EHNS-ESMO-
ESTRO(2012) 
Stage 1 Radiotherapy only Radiotherapy only 
Stage 2 
RadioChemotherapy : 
Concurent + Adjuvan 
(2A),Concurent (2B) 






Concurent + Adjuvan 
(2A),Concurent (2B) 
Or Induction + Concurent 
(2B) 
RadioChemotherapy: 




Concurent + Adjuvan 
(2A),Concurent (2B) 
Or Induction + Concurent 
(2B) 
RadioChemotherapy: 
Concurent ± Adjuvant 1A 




Chemotherapy or  
RadioChemotherapy 
 
Also, drug of choice for adjuvant chemotherapy in this patient is using 
combination of Cisplatin + 5 Flourouracil (PF). With present day evidence, 
the addition of concurrent cisplatin plus adjuvant PF to traditional 
fractionated radiotherapy has virtually higher development in control of 
NPC [16]. In other review, the addition of adjuvant chemotherapy in 1-3 
cycles seemed to provide benefits to patients [17]. After the combination of 
theraphy, we evaluated this patient with computed tomography iv-contrast. 
Using CT-Scan is essential not only for detection of early NPC, staging of 
the primary tumor, however it is able to be the use of for comparing 
scientific final results after theraphy and assessment of local 
lymphadenopathy [18].  
M0 No distant metastasis 
    M1  Distant metastasis 
 








Using combination of Chemoradiation following adjuvant 
chemotherapy in this patient is the best therapy for this patient. Beside that, 
early diagnosis in NPC was giving better result of this management. It 
clearly see the stadium tumor was reduce in CT-Scan evaluation after using 
that combination therapy. 
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